Given the intrinsic phenotypic plasticity of glioma cells, we sought to determine whether the STAT3 signaling axis could be a potential compensatory mechanism that is adopted by surviving HDAC1-deficient hGSCs. Here, STAT3 is linked to central nervous system cancer.